NEW YORK (Thomson Financial) - Bristol-Myers Squibb Co. Tuesday said it and partner Osuka Pharmaceutical Co. have received approval of a supplemental new drug application for the use of Abilify as an add-on treatment for depression from the Food and Drug Adminstration.
From: www.iii.co.uk
AFX UK Focus) 2007-11-20 16:31 GMT: Bristol-Myers, Osuka get FDA ok for Abilify as add-on depression treatment
Posted by Ruslan Abuzant at 9:25 AM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment